Race Oncology (RAC AU)

Analysis

Health Care • Australia

Race Oncology Limited operates as a specialty pharmaceutical company. The Company focuses on rediscovering and bringing to market the cancer chemotherapy agent, Bisantrene.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00